Hepatocarcinogenesis is the sequel to hepatitis in Z#2 α1‐antitrypsin transgenic mice: Histopathological and DNA ploidy studies
Stephen A. Geller, W. Stephen Nichols, Sungsook Kim, Tanya Tolmachoff, Stephen Lee, Mark J. Dycaico, Katherine Felts, Joseph A. Sorge – 1 February 1994 – Z mutant–associated α1‐antitrypsin deficiency in human beings leads to hepatitis and, in some cases, hepatocellular carcinoma. To begin to delineate the molecular basis for the development of hepatocellular carcinoma in α1‐antitrypsin deficiency, we previously developed transgenic mice using human α1‐antitrypsin M and Z genomic clones.